Suppr超能文献

蜂胶对病毒性呼吸道疾病的影响。

The Effects of Propolis on Viral Respiratory Diseases.

机构信息

Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants-National Research Institute, Wojska Polskiego 71b, 60-630 Poznań, Poland.

Chair and Department of Medical Microbiology, Poznań University of Medical Sciences, Rokietnicka 10, 60-806 Poznań, Poland.

出版信息

Molecules. 2023 Jan 1;28(1):359. doi: 10.3390/molecules28010359.

Abstract

Propolis remains an interesting source of natural chemical compounds that show, among others, antibacterial, antifungal, antiviral, antioxidative and anti-inflammatory activities. Due to the growing incidence of respiratory tract infections caused by various pathogenic viruses, complementary methods of prevention and therapy supporting pharmacotherapy are constantly being sought out. The properties of propolis may be important in the prevention and treatment of respiratory tract diseases caused by viruses such as severe acute respiratory syndrome coronavirus 2, influenza viruses, the parainfluenza virus and rhinoviruses. One of the main challenges in recent years has been severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing COVID-19. Recently, an increasing number of studies are focusing on the activity of various propolis preparations against SARS-CoV-2 as an adjuvant treatment for this infection. Propolis has shown a few key mechanisms of anti-SARS-CoV-2 action such as: the inhibition of the interaction of the S1 spike protein and ACE-2 protein; decreasing the replication of viruses by diminishing the synthesis of RNA transcripts in cells; decreasing the particles of coronaviruses. The anti-viral effect is observed not only with extracts but also with the single biologically active compounds found in propolis (e.g., apigenin, caffeic acid, chrysin, kaempferol, quercetin). Moreover, propolis is effective in the treatment of hyperglycemia, which increases the risk of SARS-CoV-2 infections. The aim of the literature review was to summarize recent studies from the PubMed database evaluating the antiviral activity of propolis extracts in terms of prevention and the therapy of respiratory tract diseases (in vitro, in vivo, clinical trials). Based upon this review, it was found that in recent years studies have focused mainly on the assessment of the effectiveness of propolis and its chemical components against COVID-19. Propolis exerts wide-spectrum antimicrobial activities; thus, propolis extracts can be an effective option in the prevention and treatment of co-infections associated with diseases of the respiratory tract.

摘要

蜂胶仍然是一种有趣的天然化合物来源,具有抗菌、抗真菌、抗病毒、抗氧化和抗炎活性。由于各种致病病毒引起的呼吸道感染发病率不断上升,人们一直在不断寻找支持药物治疗的补充预防和治疗方法。蜂胶的特性可能对预防和治疗由严重急性呼吸综合征冠状病毒 2、流感病毒、副流感病毒和鼻病毒等病毒引起的呼吸道疾病很重要。近年来的主要挑战之一是导致 COVID-19 的严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)。最近,越来越多的研究集中在各种蜂胶制剂对 SARS-CoV-2 的活性上,作为这种感染的辅助治疗。蜂胶表现出几种针对 SARS-CoV-2 的关键作用机制,例如:抑制 S1 刺突蛋白和 ACE-2 蛋白的相互作用;通过减少细胞中 RNA 转录物的合成来减少病毒的复制;减少冠状病毒颗粒。抗病毒作用不仅在提取物中观察到,而且在蜂胶中发现的单一生物活性化合物(如芹菜素、咖啡酸、白杨素、山奈酚、槲皮素)中也观察到。此外,蜂胶在治疗可导致 SARS-CoV-2 感染风险增加的高血糖症方面有效。文献综述的目的是总结来自 PubMed 数据库的最新研究,评估蜂胶提取物在预防和治疗呼吸道疾病方面的抗病毒活性(体外、体内、临床试验)。根据这项综述,近年来的研究主要集中在评估蜂胶及其化学成分对 COVID-19 的有效性上。蜂胶具有广谱抗菌活性;因此,蜂胶提取物可以成为预防和治疗与呼吸道疾病相关的合并感染的有效选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f06d/9824023/dddbe8e7bc30/molecules-28-00359-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验